美国退伍军人的死亡率,医生记录的诊断是酸酶缺乏症
Erin Zagadailov1, Hanny Al-Samkari2, Audra N Boscoe3
1Formerly of Agios Pharmaceuticals, Inc., Cambridge, MA, USA.
Hematology (Amsterdam, Netherlands)
|December 14, 2023
概括
皮鲁酸酶 (PK) 缺乏症患者面临更高的死亡风险. 这项研究发现,与匹配的队列相比,PK缺乏症患者的整体存活时间明显较短,这突显了相当大的临床负担.
科学领域:
- 血液学 血液学 血液学
- 罕见疾病 罕见疾病
- 流行病学 流行病学
背景情况:
- 关于罕见的遗传疾病 - - 酸盐激酶 (PK) 缺陷及其对死亡率的影响的现实数据有限.
- 估计PK缺乏症患者的死亡风险对于了解疾病负担至关重要.
研究的目的:
- 在大型医疗保健数据库中识别PK缺乏症患者.
- 为了比较患有PK缺乏症的患者的整体存活期 (OS) 与没有这种情况的匹配队列.
- 描述PK缺乏症患者的临床负担,包括贫血和铁过载.
主要方法:
- 使用美国退伍军人卫生管理局 (VHA) 数据库 (1995-2019) 的回顾性观察研究.
- 通过诊断代码和医生文档识别了PK缺乏症患者.
- 匹配PK缺陷队列 (n=18) 1: 5与一个非PK缺陷队列 (n=90).
- 从两个队列之间的索引日期开始,比较总生存率 (OS).
主要成果:
- 与非PK缺乏症队列 (17.1年) 相比,患有PK缺乏症的患者的中位寿命显著缩短 (10.9年).
- 在PK缺陷队列中,死亡风险比为2.3 (p=0.0306).
- 在索引后的第一年内,75%的PK缺乏症患者患有贫血,40%患有铁过载.
结论:
- 这项研究是第一个在现实世界中进行的研究,以描述PK缺乏症患者的死亡率.
- 基因酶缺乏症与增加的死亡风险和显著的临床负担有关.
- 调查结果强调需要更好的管理策略和进一步研究PK缺陷结果.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.5K
15:43Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
18.2K
相关概念视频
01:20Inborn Errors of Metabolism
164
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
164
01:20Fates of Pyruvate
8.5K
Pyruvate is the end product of glycolysis, where glucose is oxidized to pyruvate, simultaneously reducing NAD+ to NADH. Two molecules of ATP are also produced by substrate-level phosphorylation.
In aerobic organisms, pyruvate is metabolized via the citric acid cycle to produce reduced coenzymes NADH and FADH2. These coenzymes are then oxidized in the electron transport chain to produce ATP and, in the process, regenerate the NAD+ and FAD. As seen in some cell types and organisms, fermentation...
In aerobic organisms, pyruvate is metabolized via the citric acid cycle to produce reduced coenzymes NADH and FADH2. These coenzymes are then oxidized in the electron transport chain to produce ATP and, in the process, regenerate the NAD+ and FAD. As seen in some cell types and organisms, fermentation...
8.5K